Clinical Trial Update: Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative olaparib with cisplatin, with durvalumab, or alone (or no treatment) in patients planned for surgery for head and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Durvalumab (durvalumab)
• Olaparib (Olaparib)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED